Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	115.4	162.6	206.39	216.23	183.85
Trading Asset Securities	-	-	-	12.17	24.94
Cash & Short-Term Investments	115.4	162.6	206.39	228.4	208.8
Cash Growth	-29.03%	-21.21%	-9.64%	9.39%	555.64%
Accounts Receivable	-	-	2.54	23.75	18.75
Other Receivables	1.67	1.07	1.79	2.41	1.34
Receivables	1.67	1.07	4.33	26.16	20.09
Prepaid Expenses	-	2.01	1.15	1.3	0.15
Other Current Assets	-	-	-	-	-0
Total Current Assets	117.07	165.68	211.87	255.86	229.03
Property, Plant & Equipment	7.74	10.52	9.53	9.17	0.41
Other Intangible Assets	0.07	0.07	0.03	0.03	0.03
Long-Term Deferred Charges	-	-	-	0.48	0.55
Other Long-Term Assets	28.6	31.92	0.05	0.02	0.01
Total Assets	153.48	208.19	221.48	265.56	230.03
Accounts Payable	3.68	1.33	2.31	2.75	1.61
Accrued Expenses	-	6.08	7.58	9.3	9.68
Current Portion of Leases	1.29	1.46	1.15	1.35	0.28
Current Income Taxes Payable	0.02	-	0.08	0.03	-
Current Unearned Revenue	-	8.34	19.87	16.26	-
Other Current Liabilities	4.1	3.41	8	1.69	1.61
Total Current Liabilities	9.1	20.61	38.99	31.37	13.18
Long-Term Leases	2.15	4.27	4.37	5.82	0.01
Long-Term Deferred Tax Liabilities	5.2	12.05	21.08	29.4	31.13
Other Long-Term Liabilities	0.82	0	0.03	4.91	6.86
Total Liabilities	17.27	36.93	64.46	71.5	51.18
Common Stock	0.37	0.37	0.34	0.33	0.33
Additional Paid-In Capital	128.99	128.99	83.32	81.53	60.35
Retained Earnings	-8.76	29.56	64.71	107.46	116.87
Comprehensive Income & Other	15.62	12.35	8.65	4.74	1.31
Shareholders' Equity	136.21	171.26	157.02	194.06	178.85
Total Liabilities & Equity	153.48	208.19	221.48	265.56	230.03
Total Debt	3.44	5.73	5.51	7.17	0.28
Net Cash (Debt)	111.96	156.88	200.87	221.23	208.51
Net Cash Growth	-28.63%	-21.90%	-9.20%	6.10%	556.60%
Net Cash Per Share	0.35	0.52	0.69	0.77	0.70
Filing Date Shares Outstanding	326.55	326.55	294.69	289.62	284.79
Total Common Shares Outstanding	326.55	326.55	294.69	289.62	284.79
Working Capital	107.97	145.07	172.89	224.49	215.85
Book Value Per Share	0.42	0.52	0.53	0.67	0.63
Tangible Book Value	136.14	171.19	156.99	194.02	178.82
Tangible Book Value Per Share	0.42	0.52	0.53	0.67	0.63
Machinery	-	4.97	3.44	1.46	0.2

Source: S&P Capital IQ. Standard template. Financial Sources.